In collaboration with the Hellenic Medicines Verification Organisation (HMVO), Solidsoft Reply, a Reply Group company specialising in Microsoft Azure cloud-based enterprise solutions, has successfully integrated Greece’s Hellenic Medicines Verification System (HMVS) within the European Hub, delivering the launch on schedule. This achievement enhances Greece’s pharmaceutical landscape and protects its citizens from the growing threat of falsified medications. This press release features multimed...

LUMENION has successfully completed the test operation of a plant for the supply of "green steam" in combination with a large-scale thermal storage solution. The completion of this LUMENION solution marks an important milestone on the way to a decarbonized industry. The TÜV-certified system is available for applications in all industrial sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250318462006/en/LUMENION TES LUMENION's t...

Today, Venture Global received approval from the U.S. Department of Energy to export liquefied natural gas (LNG) to non-FTA countries for its third project, CP2 LNG, located in Cameron Parish, Louisiana. Venture Global CEO Mike Sabel issued the following statement: “CP2 LNG is a vital project for the U.S. economy, balance of trade, and global energy security. We are grateful for the Trump Administration’s return to regular order and regulatory certainty that will allow us to further expand U.S...

LEO Pharma A/S, a global leader in medical dermatology, today presented late-breaking data showcasing responses in a subgroup of patients from the DELTA 1 and 2 trials at the 83rd American Academy of Dermatology (AAD) 2025 Annual Meeting.1 The presentation marks the third consecutive year that LEO Pharma has presented late-breaking data at AAD. Alongside this presentation, new systemic exposure data has also been shared for delgocitinib cream at the meeting.2 “The data unveiled today further ...